{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:06:19Z","timestamp":1784167579233,"version":"3.55.0"},"reference-count":34,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Fine-needle aspiration is an effective tool for sampling thyroid nodules; its results are classified according to the Bethesda System for Reporting Thyroid Cytopathology (BSRTC), whose categories define malignancy risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To compare the histologic outcomes and disease-free survival (DFS) with the preceding BSRTC categories, we hypothesized that the initial cytologic categories may reflect long-term outcomes in follicular thyroid carcinoma (FTC), similar to those observed in papillary thyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>This retrospective study enrolled 134 patients with FTC who underwent preoperative cytology between April 2011 and December 2020. Results were classified into 6 categories according to the BSRTC: nondiagnostic, benign, atypia of uncertain significance (AUS), follicular neoplasm (FN), suspicious for malignancy, or malignant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>\n                      Overall, 8 of 134 patients (6.0%) were categorized as having a nondiagnostic FTC, 35 of 134 (26.1%) as benign, 51 of 134 (38.1%) as AUS, and 40 of 134 (29.9%) as FN. No lesions were classified as suspicious for malignancy or malignant. The nondiagnostic, AUS, and FN categories were associated with a progressively higher risk of vascular invasion, disease recurrence, and high-risk FTC, based on the 2022 World Health Organization classification (\n                      <jats:italic>P<\/jats:italic>\n                      for trend = .01, .01, and .01, respectively). Disease-free survival was lower in the FN group (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      = .01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>The initial BSRTC results may reflect not only the risk of malignancy but also the presence of vascular invasion and poor prognosis when the thyroid nodule is diagnosed as FTC. These results may provide prognostic information for therapeutic decision-making and clinical management of FTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0304-oa","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:36:39Z","timestamp":1735518999000},"page":"868-873","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic Implications of the Bethesda System in Fine-Needle Aspiration for Follicular Thyroid Carcinoma"],"prefix":"10.5858","volume":"149","author":[{"given":"Hyunju","family":"Park","sequence":"first","affiliation":[{"name":"the Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea (Park)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Lyun","family":"Oh","sequence":"additional","affiliation":[{"name":"the Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (Oh, Han)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung Kyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"the Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (MK Kim, Hahn)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Yeon","family":"Hahn","sequence":"additional","affiliation":[{"name":"the Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (MK Kim, Hahn)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ho","family":"Choe","sequence":"additional","affiliation":[{"name":"the Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (Choe)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Ki","family":"Chung","sequence":"additional","affiliation":[{"name":"the Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (MK Chung)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogyeong","family":"Han","sequence":"additional","affiliation":[{"name":"the Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (Oh, Han)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (SW Kim, JH Chung, TH Kim)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Chung","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (SW Kim, JH Chung, TH Kim)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyuk","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (SW Kim, JH Chung, TH Kim)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"18","key":"i1543-2165-149-9-868-b01","series-title":"JAMA","first-page":"2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973-2002","volume":"295","author":"Davies","year":"2006","unstructured":"Davies L,\nWelch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164\u20132167. doi:10.1001\/jama.295.18.2164"},{"issue":"1","key":"i1543-2165-149-9-868-b02","series-title":"J Med Assoc GA","first-page":"33","article-title":"The role of fine-needle aspiration biopsy in the diagnosis and management of palpable masses","volume":"85","author":"Crosby","year":"1996","unstructured":"Crosby JH. The role of fine-needle aspiration biopsy in the diagnosis and management of palpable masses. J Med Assoc GA. 1996;85(1):33\u201336."},{"issue":"1","key":"i1543-2165-149-9-868-b03","series-title":"Mayo Clin Proc","first-page":"44","article-title":"Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect","volume":"69","author":"Gharib","year":"1994","unstructured":"Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994;69(1):44\u201349. doi:10.1016\/s0025-6196(12)61611-5"},{"issue":"1","key":"i1543-2165-149-9-868-b04","series-title":"Thyroid","first-page":"1","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","unstructured":"Haugen BR,\nAlexander EK,\nBible KC, et al.. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133. doi:10.1089\/thy.2015.0020"},{"issue":"6","key":"i1543-2165-149-9-868-b05","series-title":"Diagn Cytopathol","first-page":"425","article-title":"Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference","volume":"36","author":"Baloch","year":"2008","unstructured":"Baloch ZW,\nLiVolsi VA,\nAsa SL, et al.. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6):425\u2013437. doi:10.1002\/dc.20830"},{"issue":"11","key":"i1543-2165-149-9-868-b06","series-title":"Ann Surg Oncol","first-page":"3484","article-title":"Does Bethesda category predict aggressive features in malignant thyroid nodules","volume":"20","author":"Kleiman","year":"2013","unstructured":"Kleiman DA,\nBeninato T,\nSoni A,\nShou Y,\nZarnegar R,\nFahey TJ III. Does Bethesda category predict aggressive features in malignant thyroid nodules? Ann Surg Oncol. 2013;20(11):3484\u20133490. doi:10.1245\/s10434-013-3076-5"},{"issue":"2","key":"i1543-2165-149-9-868-b07","series-title":"Thyroid","first-page":"256","article-title":"Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis","volume":"26","author":"Liu","year":"2016","unstructured":"Liu X,\nMedici M,\nKwong N, et al.. Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis. Thyroid. 2016;26(2):256\u2013261. doi:10.1089\/thy.2015.0376"},{"issue":"4","key":"i1543-2165-149-9-868-b08","series-title":"Cancer Cytopathol","first-page":"245","article-title":"Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology","volume":"120","author":"VanderLaan","year":"2012","unstructured":"VanderLaan PA,\nMarqusee E,\nKrane JF. Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology. Cancer Cytopathol. 2012;120(4):245\u2013253. doi:10.1002\/cncy.21189"},{"issue":"4","key":"i1543-2165-149-9-868-b09","series-title":"Am J Clin Pathol","first-page":"572","article-title":"Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance","volume":"136","author":"VanderLaan","year":"2011","unstructured":"VanderLaan PA,\nMarqusee E,\nKrane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol. 2011;136(4):572\u2013577. doi:10.1309\/AJCPO0BQ2YSKPXXP"},{"issue":"12","key":"i1543-2165-149-9-868-b10","series-title":"Endocr Connect","first-page":"1226","article-title":"Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma","volume":"7","author":"Henke","year":"2018","unstructured":"Henke LE,\nPfeifer JD,\nBaranski TJ, et al. Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma. Endocr Connect. 2018;7(12):1226\u20131235. doi:10.1530\/EC-18-0264"},{"issue":"11","key":"i1543-2165-149-9-868-b11","series-title":"Cancer","first-page":"2269","article-title":"The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma","volume":"103","author":"Machens","year":"2005","unstructured":"Machens A,\nHolzhausen HJ,\nDralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer. 2005;103(11):2269\u20132273. doi:10.1002\/cncr.21055"},{"issue":"6","key":"i1543-2165-149-9-868-b12","series-title":"Clin Oncol (R Coll Radiol)","first-page":"329","article-title":"Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960\u20132000","volume":"15","author":"Chow","year":"2003","unstructured":"Chow S-M,\nLaw SCK,\nAu S-K, et al.. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960\u20132000. Clin Oncol (R Coll Radiol). 2003;15(6):329\u2013336. doi:10.1016\/S0936-6555(03)00066-9"},{"issue":"1","key":"i1543-2165-149-9-868-b13","series-title":"Diagn Cytopathol","first-page":"41","article-title":"Diagnosis of \u201cfollicular neoplasm\u201d: a gray zone in thyroid fine-needle aspiration cytology","volume":"26","author":"Baloch","year":"2002","unstructured":"Baloch ZW,\nFleisher S,\nLiVolsi VA,\nGupta PK. Diagnosis of \u201cfollicular neoplasm\u201d: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26(1):41\u201344. doi:10.1002\/dc.10043"},{"issue":"5","key":"i1543-2165-149-9-868-b14","series-title":"Diagn Cytopathol","first-page":"330","article-title":"Does Hurthle cell lesion\/neoplasm predict malignancy more than follicular lesion\/neoplasm on thyroid fine-needle aspiration","volume":"34","author":"Pu","year":"2006","unstructured":"Pu RT,\nYang J,\nWasserman PG,\nBhuiya T,\nGriffith KA,\nMichael CW. Does Hurthle cell lesion\/neoplasm predict malignancy more than follicular lesion\/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol. 2006;34(5):330\u2013334. doi:10.1002\/dc.20440"},{"issue":"7","key":"i1543-2165-149-9-868-b15","series-title":"Ann Surg Oncol","first-page":"2326","article-title":"Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management","volume":"21","author":"Lee","year":"2014","unstructured":"Lee KH,\nShin JH,\nOh YL,\nHahn SY. Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management. Ann Surg Oncol. 2014;21(7):2326\u20132331. doi:10.1245\/s10434-014-3568-y"},{"key":"i1543-2165-149-9-868-b16","series-title":"The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes","author":"Ali","year":"2023","unstructured":"Ali SZ,\nVanderLaan PA. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes. 3rd ed. Springer; 2023."},{"key":"i1543-2165-149-9-868-b17","series-title":"AFIP Atlas of Tumor Pathology Series 4: Tumors of the Thyroid and Parathyroid Glands","author":"Rosai","year":"2015","unstructured":"Rosai J,\nDeLellis RA,\nCarcangiu ML,\nFrable WJ,\nTallini G, eds. AFIP Atlas of Tumor Pathology Series 4: Tumors of the Thyroid and Parathyroid Glands. American Registry of Pathology Press; 2015."},{"issue":"1","key":"i1543-2165-149-9-868-b18","series-title":"Endocr Pathol","first-page":"27","article-title":"Overview of the 2022 Who Classification of Thyroid Neoplasms","volume":"33","author":"Baloch","year":"2022","unstructured":"Baloch ZW,\nAsa SL,\nBarletta JA, et al. Overview of the 2022 Who Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27\u201363. doi:10.1007\/s12022-022-09707-3"},{"key":"i1543-2165-149-9-868-b19","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","unstructured":"Amin MB,\nEdge SB,\nGreene FL, et al. eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer International Publishing; 2017."},{"issue":"6","key":"i1543-2165-149-9-868-b20","series-title":"Cytopathology","first-page":"385","article-title":"Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology","volume":"24","author":"Dincer","year":"2013","unstructured":"Dincer N,\nBalci S,\nYazgan A, et al.. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology. Cytopathology. 2013;24(6):385\u2013390. doi:10.1111\/cyt.12021"},{"issue":"10","key":"i1543-2165-149-9-868-b21","series-title":"Diagn Cytopathol","first-page":"710","article-title":"Implications of the proposed thyroid fine-needle aspiration category of \u201cfollicular lesion of undetermined significance\u201d: a five-year multi-institutional analysis","volume":"37","author":"Layfield","year":"2009","unstructured":"Layfield LJ,\nMorton MJ,\nCramer HM,\nHirschowitz S. Implications of the proposed thyroid fine-needle aspiration category of \u201cfollicular lesion of undetermined significance\u201d: a five-year multi-institutional analysis. Diagn Cytopathol. 2009;37(10):710\u2013714. doi:10.1002\/dc.21093"},{"issue":"4","key":"i1543-2165-149-9-868-b22","series-title":"Acta Cytol","first-page":"361","article-title":"Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system","volume":"56","author":"Ust\u00fcn","year":"2012","unstructured":"Ust\u00fcn H,\nAstarc\u0131 HM,\nAltunkaya C, et al.. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system. Acta Cytol. 2012;56(4):361\u2013369. doi:10.1159\/000338218"},{"issue":"1","key":"i1543-2165-149-9-868-b23","series-title":"Arch Endocrinol Metab","first-page":"12","article-title":"Does the Bethesda category predict aggressive features in differentiated thyroid cancer","volume":"63","author":"Lima","year":"2019","unstructured":"Lima ARLR,\nMedeiros KMM,\nParente CMRV, et al.. Does the Bethesda category predict aggressive features in differentiated thyroid cancer? Arch Endocrinol Metab. 2019;63(1):12\u201315. doi:10.20945\/2359-3997000000098"},{"issue":"6","key":"i1543-2165-149-9-868-b24","series-title":"Thyroid","first-page":"751","article-title":"Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (eighth edition): what changed and why","volume":"27","author":"Tuttle","year":"2017","unstructured":"Tuttle RM,\nHaugen B,\nPerrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (eighth edition): what changed and why? Thyroid. 2017;27(6):751\u2013756. doi:10.1089\/thy.2017.0102"},{"issue":"3","key":"i1543-2165-149-9-868-b25","series-title":"Thyroid","first-page":"373","article-title":"An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC\/UICC staging system for well-differentiated thyroid cancer","volume":"26","author":"Nixon","year":"2016","unstructured":"Nixon IJ,\nWang LY,\nMigliacci JC, et al.. An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC\/UICC staging system for well-differentiated thyroid cancer. Thyroid. 2016;26(3):373\u2013380. doi:10.1089\/thy.2015.0315"},{"issue":"10","key":"i1543-2165-149-9-868-b26","series-title":"Thyroid","first-page":"1229","article-title":"Follicular thyroid carcinoma: a perspective","volume":"28","author":"Daniels","year":"2018","unstructured":"Daniels GH. Follicular thyroid carcinoma: a perspective. Thyroid. 2018;28(10):1229\u20131242. doi:10.1089\/thy.2018.0306"},{"key":"i1543-2165-149-9-868-b27","series-title":"Oral Oncol","first-page":"97","article-title":"Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: a multicenter cohort study","volume":"87","author":"Kim","year":"2018","unstructured":"Kim M,\nKim HI,\nJeon MJ, et al.. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: a multicenter cohort study. Oral Oncol. 2018;87:97\u2013103. doi:10.1016\/j.oraloncology.2018.10.029"},{"issue":"6","key":"i1543-2165-149-9-868-b28","series-title":"Endocr J","first-page":"829","article-title":"Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma","volume":"60","author":"Ito","year":"2013","unstructured":"Ito Y,\nHirokawa M,\nMasuoka H, et al.. Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. Endocr J. 2013;60(6):829\u2013833. doi:10.1507\/endocrj.ej12-0454"},{"issue":"2","key":"i1543-2165-149-9-868-b29","series-title":"Mod Pathol","first-page":"186","article-title":"Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations","volume":"35","author":"Park","year":"2022","unstructured":"Park H,\nShin HC,\nYang H, et al.. Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations. Mod Pathol. 2022;35(2):186\u2013192. doi:10.1038\/s41379-021-00907-6"},{"issue":"5","key":"i1543-2165-149-9-868-b30","series-title":"Ann Surg Oncol","first-page":"2916","article-title":"Selection criteria for completion thyroidectomy in follicular thyroid carcinoma using primary tumor size and TERT promoter mutational status","volume":"30","author":"Park","year":"2023","unstructured":"Park H,\nHeo J,\nKi CS, et al.. Selection criteria for completion thyroidectomy in follicular thyroid carcinoma using primary tumor size and TERT promoter mutational status. Ann Surg Oncol. 2023;30(5):2916\u20132925. doi:10.1245\/s10434-022-13089-5"},{"issue":"1","key":"i1543-2165-149-9-868-b31","series-title":"Korean J Radiol","first-page":"103","article-title":"Association of ultrasonography features of follicular thyroid carcinoma with tumor invasiveness and prognosis based on WHO classification and TERT promoter mutation","volume":"25","author":"Kim","year":"2024","unstructured":"Kim MK,\nPark H,\nOh YL,\nShin JH,\nKim TH,\nHahn SY. Association of ultrasonography features of follicular thyroid carcinoma with tumor invasiveness and prognosis based on WHO classification and TERT promoter mutation. Korean J Radiol. 2024;25(1):103\u2013112. doi:10.3348\/kjr.2023.0461"},{"issue":"4","key":"i1543-2165-149-9-868-b32","series-title":"Acta Cytol","first-page":"378","article-title":"Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland","volume":"49","author":"Clary","year":"2005","unstructured":"Clary KM,\nCondel JL,\nLiu Y,\nJohnson DR,\nGrzybicki DM,\nRaab SS. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland. Acta Cytol. 2005;49(4):378\u2013382. doi:10.1159\/000326169"},{"issue":"2","key":"i1543-2165-149-9-868-b33","series-title":"Endocr Relat Cancer","first-page":"305","article-title":"Characterization of thyroid \u2018follicular neoplasms\u2019 in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application","volume":"12","author":"Saggiorato","year":"2005","unstructured":"Saggiorato E,\nDe Pompa R,\nVolante M, et al.. Characterization of thyroid \u2018follicular neoplasms\u2019 in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer. 2005;12(2):305\u2013317. doi:10.1677\/erc.1.00944"},{"issue":"4","key":"i1543-2165-149-9-868-b34","series-title":"Endocrinol Metab Clin North Am","first-page":"761","article-title":"Follicular thyroid cancer","volume":"24","author":"Grebe","year":"1995","unstructured":"Grebe SK,\nHay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am. 1995;24(4):761\u2013801. doi:10.1016\/S0889-8529(18)30021-5"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/9\/article-p868.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/149\/9\/868\/3538196\/i1543-2165-149-9-868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/9\/article-p868.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/149\/9\/article-p868.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:55:06Z","timestamp":1784166906000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/149\/9\/article-p868.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0304-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}